Arkolith/Insider Trading/FULC/Form 4

Gould Robert J

DirectorFulcrum Therapeutics, Inc. (FULC) · full profile →Form 4 · filed Jun 8, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$578K
Net Open-Market Flow
-$578K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 7, 2022Sell(S)71K$8.09$578K507K
Jun 7, 2022Option exercise(M)71K$7.84$560K578K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 7, 2022Option exercise(M)71K—$087K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-22-021530) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML